GLP-1 medications like semaglutide and tirzepatide have become household names, helping millions manage weight and metabolic health. But as prescriptions have surged, so have reports from patients noticing something unexpected: changes in their mouths. From dry mouth to sensitive teeth, oral health concerns are showing up with enough regularity that dentists and researchers are paying close attention.
While clinical trials focused heavily on weight loss outcomes and metabolic markers, post-market data has surfaced meaningful patterns around oral health that deserve dedicated attention. These aren't rare anecdotes. They're consistent enough themes that major dental organizations have started issuing guidance for patients using these medications. Understanding the biological reasons behind these changes helps you catch issues early and make informed decisions about your care.